Author

Margrit Wiesendanger

Observed name: M. Wiesendanger

Institution: Icahn School of Medicine at Mount Sinai

Observed institutions: Albert Einstein College of Medicine, Columbia University Irving Medical Center, Columbia University, Icahn School of Medicine at Mount Sinai

OpenAlex ID: A5055705389

Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern

2000 · Margrit Wiesendanger, Burkhard Kneitz, et al. · The Journal of Experimental Medicine · 195

Immunologic characteristics of intrarenal T cells: Trafficking of expanded CD8+ T cell β‐chain clonotypes in progressive lupus nephritis

2011 · Robert Winchester, Margrit Wiesendanger, et al. · Arthritis & Rheumatism · 118

Circulating Activated and Effector Memory T Cells Are Associated with Calcification and Clonal Expansions in Bicuspid and Tricuspid Valves of Calcific Aortic Stenosis

2011 · Robert Winchester, Margrit Wiesendanger, et al. · The Journal of Immunology · 63

Somatic Hypermutation, Transcription, and DNA Mismatch Repair

1998 · Margrit Wiesendanger, Matthew D Scharff, et al. · Cell · 43

The Dendritic Cell-T Cell Synapse as a Determinant of Autoimmune Pathogenesis

2005 · Mirentxu Iruretagoyena, Margrit Wiesendanger, et al. · Current Pharmaceutical Design · 27

Novel therapeutics for systemic lupus erythematosus

2006 · Margrit Wiesendanger, Anfisa Stanevsky, et al. · Current Opinion in Rheumatology · 16

T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome

2025 · Cansu Cimen Bozkus, Matthew Brown, et al. · iScience · 6

Tolérance et efficacité du zola-cel, une thérapie par cellules CAR T ciblant le CD19, dans le lupus érythémateux systémique (LES) sévère et réfractaire : mise à jour de l’étude Breakfree-1

2026 · D. Simon, M. Wiesendanger, et al. · La Revue de Médecine Interne

OC.57 Safety and efficacy of CD19 NEX-T® (BMS-986353), a chimeric antigen receptor (CAR) T cell therapy, in systemic sclerosis (SSc): findings from the breakfree-1 trial

2026 · Dinesh Khanna, David S Korman, et al.

S15:01 Safety and efficacy of CD19 NEX-T® (BMS-986353)—a CD19-directed chimeric antigen receptor (CAR) T cell therapy—for severe refractory systemic lupus erythematosus (SLE): breakfree-1 trial update

2026 · David Simon, Margrit Wiesendanger, et al. · Oral Presentations

Use of Immune Checkpoint Inhibitors in Patients With Rheumatologic and Immune Mediated Inflammatory Disease

2022 · Emily Carroll, Emily Gutowski, et al.

Sa.97. Effector Memory Cytotoxic T Lymphocytes in the Pathogenesis of Calcific Aortic Stenosis

2008 · Margrit Wiesendanger, Mathew Maurer, et al. · Clinical Immunology

Works count: 12

Citation count: 468

H-index: 6

I10-index: 6